Special Issue "Mechanisms of Viral Fusion and Applications in Antivirals"
Deadline for manuscript submissions: closed (31 December 2019).
Interests: mechanism of HIV-1 virus fusion employing single molecule approaches
Professor, Center for Retrovirus Research, Department of Veterinary Biosciences, Department of Microbial Infection and Immunity, The Ohio State University, 1900 Coffey Rd., Columbus, OH 43210, USA
Interests: viral membrane fusion and entry; cellular restriction factors against viral infection; retroviral oncogenesis; viral envelope glycoproteins; lentiviral vectors and gene therapy
Virus-cell fusion is essential for enveloped viruses to enter host cells. Enveloped viruses acquire their membrane from infected host cells during the budding process. Many important human pathogens are enveloped viruses, such as human immunodeficiency virus (HIV), Hepatitis C (HCV), and Ebola virus (EBOV). The virus–cell fusion process is carried out by one or more viral envelope glycoprotein or fusion proteins. Viral fusion proteins contain a typical fusion peptide or a fusion loop that is responsible for initial insertion into host membrane, and they are normally present in virions as a prefusion state, which must be triggered to mediate fusion and viral entry. The current known triggers include receptor binding, low pH, receptor-binding plus low pH, and cellular cathepsins, but may also include calcium and certain lipids. However, regardless of distinct prefusion structures and triggers, the post-fusion state of all viral fusion proteins is a trimer of hairpin.
In this Special Issue, we will focus on the most recent advances in understanding the mechanism of virus–cell fusion, with a special emphasis on advanced imaging approaches (single molecule techniques and super-resolution) and viral fusion triggers. We will also focus on new developments on neutralizing antibodies, antivirals, and vaccine development.
Dr. Sergi Padilla-Parra
Prof. Shan-Lu Liu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- virus–cell fusion mechanism
- fusion triggers
- single viral particle imaging
- membrane fusion kinetics
- advanced microscopy
- neutralizing antibodies
- small molecule fusion inhibitors
- antiviral drugs